Placebo to Ondansetron

DRUG2 trials

Sponsors

Helsinn Healthcare SA

Conditions

Chemotherapy-Induced Nausea and VomitingPostoperative Nausea and Vomiting

Phase 3

Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients

CompletedNCT01395901

Helsinn Healthcare SAPostoperative Nausea and Vomiting

Start: 2011-06-30End: 2012-04-30Updated: 2014-07-30

Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients

CompletedNCT01442376

Helsinn Healthcare SAChemotherapy-Induced Nausea and Vomiting

Start: 2011-09-30End: 2012-11-30Updated: 2014-08-07

Related Papers

Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority study.

2016-01-1928 citations

Palonosetron vs ondansetron: Prevention of chemotherapy-induced nausea and vomiting in pediatric patients in a multicycle study.

Journal of Clinical Oncology2015-05-202 citations